Recently, Eluard et al. reported the presence of a new subset of Diffuse large B-cell lymphoma (DLBCL) patients showing enhanced RelB activation with aberrant gene expression and mutation profiles [113]. Here, RELB is linked to diffuse large B-cell lymphoma.